Drawing for ISOLYMPH

USPTO serial 73085330

ISOLYMPH

Reviewed by CopyMark Law Group

Reg. 1056367Status 800Renewal
Filing date
Status date
Registration date
Jan 18, 1977
Examiner
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with ISOLYMPH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001DIAGNOSTIC REAGENT USED TO SEPARATE [ LEUCOCYTES ] * LYMPHOCYTES * FROM BLOODACTIVEApr 15, 1976

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 18, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 10, 2017NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 10, 2017RNL3REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Feb 10, 201789AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Feb 10, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 9, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 9, 2016E89RTEAS SECTION 8 & 9 RECEIVED
Jan 18, 2016REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 5, 2007CFITCASE FILE IN TICRS
Feb 14, 2007RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Feb 14, 200789AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Feb 9, 2007PLGLASSIGNED TO PARALEGAL
Jan 3, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 10, 200689AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Dec 10, 200689AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Dec 10, 2006E89RTEAS SECTION 8 & 9 RECEIVED
Dec 10, 2006ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 10, 2006REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 15, 1997RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Feb 28, 1997A7OKAMENDMENT UNDER SECTION 7 - PROCESSED
Dec 26, 19969.AFREGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8
Sep 13, 1996AMD7SEC 7 REQUEST FILED
Apr 27, 1982C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Frequently asked questions

Related guidance